text: https://t.co/Wg3VvgqndS $JNCE Jounce Therapeutics notable market movement up 5.7% = $34.5 million gain. At $631.7 million marketCap, JNCE represents 0.2% of the $361.7 billion #NASDAQ/#NYSE/A biotechnology-biological-products-no-diagnostic-substances industry. https://t.co/fP1XEkBvas
time: Wed Apr 25 16:13:38 +0000 2018
text: My holdings turned around nicely: $GBT $JNCE and yes $IRBT
time: Wed Apr 25 15:25:24 +0000 2018
text: Analysts Expect Jounce Therapeutics $JNCE to Announce -$0.31 EPS https://t.co/6E39J6eZmJ
time: Wed Apr 25 07:29:10 +0000 2018
text: Analysts Expect Jounce Therapeutics $JNCE to Announce -$0.31 EPS https://t.co/soi88WeEw8
time: Wed Apr 25 07:28:23 +0000 2018
text: Analysts Expect Jounce Therapeutics $JNCE to Announce -$0.31 EPS https://t.co/flaPBo5iKf
time: Wed Apr 25 07:28:17 +0000 2018
text: -$0.31 EPS Expected for Jounce Therapeutics $JNCE This Quarter https://t.co/rjScmYHlOw
time: Wed Apr 25 07:26:34 +0000 2018
text: RT @4thQuarterCap: Added to $CNAT $JNCE $VXRT $ZSAN $IDRA $LIFE
time: Wed Apr 25 05:00:18 +0000 2018
text: $JNCE morning selloffs are pretty consistent the past month
time: Tue Apr 24 13:51:48 +0000 2018
text: Added to $JNCE
time: Mon Apr 23 21:02:54 +0000 2018
text: $JNCE great platform but terrible stock for short term investors - probably continues to sell off until we see data
time: Mon Apr 23 17:15:46 +0000 2018
text: Zacks: Brokerages Set $33.33 Target Price for Jounce Therapeutics $JNCE https://t.co/m6S9Udk3i9
time: Mon Apr 23 10:34:58 +0000 2018
text: Brokerages Expect Jounce Therapeutics $JNCE to Announce -$0.31 Earnings Per Share https://t.co/YkvetUwWTl
time: Mon Apr 23 09:19:21 +0000 2018
text: Somewhat Positive Media Coverage Somewhat Unlikely to Impact Jounce Therapeutics $JNCE Stock Price https://t.co/iCTnuYA336
time: Mon Apr 23 07:18:30 +0000 2018
text: Jounce Therapeutics $JNCE Getting Somewhat Positive News Coverage, Report Finds https://t.co/jfeipazeSx
time: Mon Apr 23 07:16:26 +0000 2018
